Letters
Reasons for inadequate health care vary
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7269.1159 (Published 04 November 2000) Cite this as: BMJ 2000;321:1159
- Trevor M Jones, director general
- Asociation of the British Pharmaceutical Industry, London SW1A 2DY
EDITOR—The pharmaceutical industry has not “abandoned the battlefield” in the fight against tropical disease, as discussed by Schull.1 Pharmaceutical companies are still researching and developing new drugs for several diseases and have actively participated in partnership projects in recent years. These projects aim at implementing treatment access programmes in HIV/AIDS and other diseases prevalent in tropical countries, such …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.